Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer.
about
A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft modelDNA microstructure influences selective binding of small molecules designed to target mixed-site DNA sequencesEvaluation of ERG responsive proteome in prostate cancerFunctional antagonism of TMPRSS2-ERG splice variants in prostate cancer.Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancerRelative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.ETS transcription factors in embryonic vascular development.A simple, rapid, low-cost technique for naked-eye detection of urine-isolated TMPRSS2:ERG gene fusion RNA.Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.Recent advances in the structural molecular biology of Ets transcription factors: interactions, interfaces and inhibition.miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1.ERG oncoprotein expression in prostate carcinoma patients of different ethnicities.
P2860
Q27322372-5B9CCBF2-D0DD-4541-AA1D-CD5266C6B29AQ33554133-A29C54EA-7B9F-489F-A188-FAAE1265723CQ33822319-A6120FDA-5CDD-4D18-A0ED-88B3BBF915F9Q34170544-004B3FA6-E11D-4BF1-AB44-CFCB05AF1A47Q35125405-2628C9D9-E2DC-4C1E-97E5-8F40E3520FA7Q35406347-EB346E16-BA93-49F7-8F47-275BB88AE961Q35758944-9F9EFD64-F7A2-43D4-A0C5-F2913A5CB052Q37077576-490CB5D6-C228-41DE-9E23-D3153BB3987EQ37137366-D4806631-4CC6-42F3-9735-98CBDB83E1E3Q37501345-3456D529-ED02-49A8-A687-8958BDCC79ADQ37635618-71E9351B-844E-45EF-A0F0-68A670EBDCBCQ38180770-2DEB0DCC-C978-4EB5-8FFD-BE8362609BF4Q38855018-A20EF245-5D0E-46A3-A7B9-7437F82C6544Q41733293-D921A0B2-0290-4226-AF03-64C128BEF62D
P2860
Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Emergence of ETS transcription ...... ic targets in prostate cancer.
@en
type
label
Emergence of ETS transcription ...... ic targets in prostate cancer.
@en
prefLabel
Emergence of ETS transcription ...... ic targets in prostate cancer.
@en
P2860
P1476
Emergence of ETS transcription ...... ic targets in prostate cancer.
@en
P2093
Aykut Uren
Said Rahim
P2860
P304
P407
P577
2013-04-19T00:00:00Z